www.BIRDFLU-MANUAL.com
PANDEMIC PREPAREDNESS FOR BUSINESSES
PANDEMIC PREPAREDNESS FOR BUSINESSES
THE INFLUENZA MANAGER
THE INFLUENZA MANAGER
When preparing your business for a pandemic such as Bird Flu, it is imperative to nominate an Influenza Manager to 'own' or 'champion' the company's planning and response, and who will be responsible for workplace health and safety.
In larger organisations, more than one Influenza Manager should be involved, although a senior individual must the central point or 'head' and be responsible for the training and management of the departmental Business Continuity Managers.
Some of the responsibilities of the Influenza Manager will include:
Setting up a crisis system to monitor staff who are ill or suspected to be ill in the event of a pandemic, including contacting staff who are unexpectedly absent from work - has their doctor been notified of their illness? Have "contact" issues been addressed? Is someone able to care for them?
Setting up and maintaining staff emergency contact records for communication purposes. This will also include retired or ex employees who can be called upon to temporarily take over the workload should staff fall sick when no other in the company can or is able take on the additional workload.
Crisis managing stockpiles of equipment, including acquisition, storage, distribution, monitoring usage and re-ordering.
Ensure workstations are properly cleaned and disinfected by cleaning staff if employees become ill at work.
Crisis manage the communications with staff before during and after the pandemic including the placement and upkeep of notices, signs and warnings regarding the pandemic stages and general memos to staff regarding hygiene.
Crisis manage customers, clients, suppliers, the media and any other external parties updated on the company's continuity preparations to instill confidence that the Company will, as much as possible, be able to sustain a 'business as usual' stance throughout the disruption period.
Keep customers, clients, suppliers and any other external parties updated on the company's crisis response to the pandemic outbreak, and its ongoing recovery throughout the pandemic period.
Offer crisis support to staff and show concern at their well being and show contingency leadership.
Setting up a process to facilitate/encourage the return of staff to work once they are better or at the end of a quarantine period; and ensuring that the workplace has adequate supplies of tissues, medical and hand hygiene products, cleaning supplies and masks for people who become ill at work. It may be difficult to purchase such products once a pandemic begins.
The Influenza Manager's full role will vary from company to company, however these basic generic responsibilities span all company types and sizes.
As a pandemic could last many months and may contain peaks followed by periods of reduced illness, the Influenza Manager's role will be ongoing and will continue throughout the pandemic period to a point in which local Government and the WHO declare the pandemic over. Estimates suggest this period to last at least 18 months.
What kind of individual or job position should be tasked with the role of Influenza Manager? Consider the following attributes:
Examples include PA to CEO, departmental heads, existing Crisis Managers, operational heads and business owners.
As planning for Bird Flu involves all areas of a business's operations, consideration should also be given to setting up a Task Force involving expertise throughout the organisation. This will be especially important when plans involving one discipline will impact on others.
Make Bird Flu Contingency Preparations as an agenda item throughout the organisation hierarchy. All levels should of the Company should be aware of your Bird Flu preparations and what their role is to assist.
As in all Workforce Management back up preparations, consider someone to take over the role of Influenza Manager should the incumbent Influenza Manager(s) becomes absent or not in a position to fulfill his/her duties.
More help? Need a complete solution? Something with all the hard work done for you? Something with customisable templates of procedures, presentations, project timelines and tutorials … to hand hold you through it all? Then you’re looking for our Bird Flu D-I-Y eManual. It has all of this and much, much more. To learn more about it and get some free stuff click here.
|

BE SURE TO CHECK OUT BIRD FLU MANUAL
ONLINE'S OTHER TOPICS BELOW:
(Our Manual gets reviewed and updated regularly so make sure you add this page to your favorites and come back often!)ONLINE'S OTHER TOPICS BELOW:
|
|
|
Latest Bird Flu / Avian Flu News From Medical News Today.
| 01/08/2009 04:00 PM |
| Excessive Use Of Antiviral Drugs Could Aid Deadly Flu |
|
Influenza's ability to resist the effects of cheap and popular antiviral agents in Asia and Russia should serve as a cautionary tale about U.S. plans to use the antiviral Tamiflu in the event of widespread avian flu infection in humans, scientists say. Researchers analyzed almost 700 genome sequences of avian influenza strains to document where and when the virus developed resistance to a class of antiviral drugs called adamantanes and how far resistant strains spread.
|
| 01/08/2009 02:00 AM |
| Woman With Bird Flu Dies In Beijing Hospital |
|
Chinese health authorities confirmed on Tuesday that a 19-year old woman from east China who lived in Beijing and who was infected with bird flu died in a Beijing hospital at 7.20 am on Monday. The woman, named Huang Yanqing, was the first bird flu case reported in China's capital city since 2003, according to a statement released by the municipal health bureau and reported by Xinhua, the Chinese state council's news agency.
|
| 12/31/2008 02:00 AM |
| 1918 Flu Killed Millions Because Of Three Genes |
|
A team of scientists from the US and Japan have identified a combination of three genes in the flu virus that was most likely responsible for making the 1918 flu strain so deadly that it caused the most devastating outbreak of infectious disease ever known to humankind, leaving tens of millions dead in its wake.
|
| 12/17/2008 04:00 PM |
| WHO Update Of Avian Influenza Situation In Cambodia |
|
The Ministry of Health of Cambodia has announced a new confirmed case of human infection with the H5N1 avian influenza virus. The 19-year-old male, from Kandal Province, developed symptoms on 28 November and initially sought medical attention at a local health centre on 30 November. The presence of the H5N1 virus was confirmed by the National Influenza Centre, the Institut Pasteur in Cambodia, on 11 December.
|
| 12/14/2008 05:00 PM |
| Vaccines Against Avian Flu - AmVac AG Cooperates With National Health Research Institutes In Taiwan |
|
Swiss AmVac AG establishes comprehensive collaboration with the National Health Research Institutes in Taiwan to combat H5N1. H5N1/Influenza A is a flu virus known colloquially as "avian flu". "Avian flu" first occurred in Asia, and was transmitted to humans in a number of cases.AmVac's CSO Prof. Michel Klein attended the opening ceremony of the pilot plant Vaccine Centre of the National Health Research Institutes in Taiwan.
|
| 12/12/2008 04:00 PM |
| USD 12.5 M Funding For The Development Of Intercell's Vaccine Patch System For Pandemic Influenza From U.S. Department Of Health And Human Services |
|
Intercell AG (VSE: ICLL) announced the execution of a contract modification with the U.S. Department of Health and Human Services (HHS). The agreement commits additional funding of USD 12.5 m for Intercell's Pandemic Influenza program. Intercell is developing a Pandemic Influenza Vaccine Patch System that includes an immunostimulant patch administered in conjunction with an injected Pandemic Influenza vaccine (manufactured by Solvay Biologicals, B.V.
|
| 12/12/2008 04:00 PM |
| Vical Pandemic Influenza Vaccines Achieve T-Cell Responses And Cross-Clade Reactivity In Humans |
|
Vical Incorporated (Nasdaq: VICL) announced that the company's Vaxfectin(R)-formulated H5N1 pandemic influenza DNA vaccines induced T-cell responses against a matching strain of influenza virus and demonstrated cross-clade antibody responses against a different strain in a Phase 1 clinical trial. The company previously reported that the vaccines had achieved potentially protective levels of antibody responses in up to 67% of evaluable subjects in the trial's higher dose cohorts.
|
| 12/09/2008 11:00 PM |
| Over 80,000 Chickens To Be Killed In Hong Kong After Bird Flu Found |
|
Authorities in Hong Kong say over 80,000 chickens will be culled after a poultry farm was found to have chickens infected with avian influenza (bird flu). The last time bird flu was detected in Hong Kong was in 2002. About 60 dead chickens were found in the farm, according to York Chow, Health Secretary. Tests have confirmed the birds died from the H5N1 virus - the most virulent strain. He added that all chickens within a 2-mile (3-km) radius of the infected farm will be culled.
|
| 12/04/2008 02:00 AM |
| Estimating Antiviral Effectiveness Against Pandemic Influenza Using Household Data |
|
Antiviral drugs play a central role in current plans for managing an influenza pandemic. However, their ability to reduce symptoms and infectivity in cases, and to reduce susceptibility of individuals given antivirals prophylactically must be confirmed for the pandemic virus strain. We present a technique for estimating antiviral effectiveness from data that can gathered easily from infected households during the early stages of an influenza pandemic.
|
| 12/03/2008 09:00 PM |
| Effects Of Influenza A Virus Infection On Migrating Mallard Ducks |
|
Mallard ducks are a main reservoir for low-pathogenic avian influenza virus in nature, yet surprisingly little is known about how infection affects these birds. We analyzed 10,000 samples from migratory mallards in Sweden for presence of influenza virus and were able to demonstrate that infected birds were leaner than uninfected birds, and that weight loss was related to the amount of virus shed in their faeces.
|
| 12/02/2008 11:00 PM |
| Armed Forces Institute Of Pathology To Conduct NanoViricides Animal Studies Against Bird Flu |
|
NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that they have executed a Cooperative Research and Development Agreement (CRADA) with the Armed Forces Institute of Pathology (AFIP). This joint R&D effort will enable AFIP scientists to test the effectiveness of several NanoViricides, Inc. anti-viral nanomedicines against deadly bird flu viruses (H5N1) at their facilities.
|
| 11/28/2008 06:00 PM |
| Fate And Effects Of The Drug Tamiflu In The Environment |
|
The research council FORMAS in Sweden has granted 574 000 euro to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance. Tamiflu is being stockpiled all over the world for use in fighting the next influenza pandemic. However, there are growing signs that influenza viruses may develop resistance to this vital pharmaceutical, because it is routinely prescribed for seasonal influenza.
|
| 11/27/2008 06:00 PM |
| Tamiflu In The Environment |
|
The research council FORMAS, Sweden, has granted 5.9 million SEK to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance. Tamiflu is being stockpiled all over the world for use in fighting the next influenza pandemic. However, there are growing signs that influenza viruses may develop resistance to this vital pharmaceutical, because it is routinely prescribed for seasonal influenza.
|
| 11/27/2008 06:00 PM |
| Tamiflu In The Environment |
|
The research council FORMAS, Sweden, has granted 5.9 million SEK to a new research project that will study the environmental fate and effects of the anti-viral drug Tamiflu on the development on influenza resistance. Tamiflu is being stockpiled all over the world for use in fighting the next influenza pandemic. However, there are growing signs that influenza viruses may develop resistance to this vital pharmaceutical, because it is routinely prescribed for seasonal influenza.
|
| 11/26/2008 08:00 PM |
| News From The Journals Of The American Society For Microbiology |
|
New Vaccines Protect Against Asian H5N1 Influenza A Viruses in Domestic Ducks Scientists are looking at a novel strategy to prevent the spread of pandemic avian influenza. They have developed a vaccine that protects ducks, a known natural reservoir for the virus.
|
| 11/24/2008 06:00 PM |
| New Centre To Fight Infectious Diseases - China-Australia Centre For Phenomics Research |
|
The fight against infectious diseases such as Avian influenza will receive a boost today with the official opening of the China-Australia Centre for Phenomics Research at The Australian National University. The centre will be opened by ANU Vice-Chancellor Professor Ian Chubb and Professor Lu Yongxiang, President of the Chinese Academy of Sciences.
|
| 11/23/2008 04:00 PM |
| Minister For Health Dawn Primarolo To Give Evidence To Lords Science Committee On Risks Of Flu Pandemic, UK |
|
The House of Lords Science and Technology Committee, which in December 2005 published a report on the risks of pandemic influenza, will next week hold a follow-up evidence session with Dawn Primarolo MP, Minister of State for Public Health. The Committee's original report took the view that the first line of defence against a potential human influenza pandemic was effective surveillance and control of avian influenza, in particular in south east Asia.
|
| 11/14/2008 04:00 PM |
| Cleveland Clinic Recognizes New Strategies For Creating Vaccines For Avian Flu As A Top Ten Medical Innovation For 2009 |
|
Novavax, Inc. (Nasdaq: NVAX) announced that its strategy for treating avian flu through genetically-engineered virus-like particles (VLPs) was ranked as a Top Ten Innovation at Cleveland Clinic 6th Annual Medical Innovation Summit. Novavax, Inc.
|
| 11/13/2008 04:00 PM |
| A New Way To Predict Outbreaks: Replikin Peptide Concentration In H5N1 Influenza Virus Genome As A Marker For Lethal Outbreaks |
|
WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is "suboptimal" -- often correct less than 50% of the time, especially for seniors. Perhaps in part because we are not yet accurate in our predictions of upcoming influenza strains, approximately 36,000 people die each year of flu in the United States alone.
|
| 11/13/2008 04:00 PM |
| A New Way To Predict Outbreaks: Replikin Peptide Concentration In H5N1 Influenza Virus Genome As A Marker For Lethal Outbreaks |
|
WHO and CDC have stated that the predictive accuracy of their annual formulations for human influenza vaccines is "suboptimal" -- often correct less than 50% of the time, especially for seniors. Perhaps in part because we are not yet accurate in our predictions of upcoming influenza strains, approximately 36,000 people die each year of flu in the United States alone.
|









